613 related articles for article (PubMed ID: 29530977)
1. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
[TBL] [Abstract][Full Text] [Related]
2. Zbtb7c is a critical gluconeogenic transcription factor that induces glucose-6-phosphatase and phosphoenylpyruvate carboxykinase 1 genes expression during mice fasting.
Choi WI; Yoon JH; Song JY; Jeon BN; Park JM; Koh DI; Ahn YH; Kim KS; Lee IK; Hur MW
Biochim Biophys Acta Gene Regul Mech; 2019 Jun; 1862(6):643-656. PubMed ID: 30959128
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Hepatic Gluconeogenesis by Nuclear Receptor Coactivator 6.
Oh GS; Kim SR; Lee ES; Yoon J; Shin MK; Ryu HK; Kim DS; Kim SW
Mol Cells; 2022 Apr; 45(4):180-192. PubMed ID: 35258009
[TBL] [Abstract][Full Text] [Related]
4. CREB-upregulated lncRNA MEG3 promotes hepatic gluconeogenesis by regulating miR-302a-3p-CRTC2 axis.
Zhu X; Li H; Wu Y; Zhou J; Yang G; Wang W; Kang D; Ye S
J Cell Biochem; 2019 Mar; 120(3):4192-4202. PubMed ID: 30260029
[TBL] [Abstract][Full Text] [Related]
5. Small Hepatitis B Virus Surface Antigen Promotes Hepatic Gluconeogenesis via Enhancing Glucagon/cAMP/Protein Kinase A/CREB Signaling.
Chen Y; Wang B; Ou X; Wu Y; He Y; Lin X; Lin X
J Virol; 2022 Dec; 96(23):e0102022. PubMed ID: 36394315
[TBL] [Abstract][Full Text] [Related]
6. The role of vasodilator-stimulated phosphoprotein (VASP) in the control of hepatic gluconeogenic gene expression.
Tateya S; Rizzo-De Leon N; Cheng AM; Dick BP; Lee WJ; Kim ML; O'Brien K; Morton GJ; Schwartz MW; Kim F
PLoS One; 2019; 14(4):e0215601. PubMed ID: 31017943
[TBL] [Abstract][Full Text] [Related]
7. B-cell translocation gene-2 increases hepatic gluconeogenesis via induction of CREB.
Hwang SL; Kwon O; Lee SJ; Roh SS; Kim YD; Choi JH
Biochem Biophys Res Commun; 2012 Nov; 427(4):801-5. PubMed ID: 23058912
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone promotes hepatic gluconeogenesis by enhancing BTG2-YY1 signaling pathway.
Jo JR; An S; Ghosh S; Nedumaran B; Kim YD
Sci Rep; 2021 Sep; 11(1):18999. PubMed ID: 34556771
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 4 signaling is required for induction of gluconeogenic gene expression by palmitate in human hepatic carcinoma cells.
Mamedova LK; Yuan K; Laudick AN; Fleming SD; Mashek DG; Bradford BJ
J Nutr Biochem; 2013 Aug; 24(8):1499-507. PubMed ID: 23465595
[TBL] [Abstract][Full Text] [Related]
10. Control of blood glucose in the absence of hepatic glucose production during prolonged fasting in mice: induction of renal and intestinal gluconeogenesis by glucagon.
Mutel E; Gautier-Stein A; Abdul-Wahed A; Amigó-Correig M; Zitoun C; Stefanutti A; Houberdon I; Tourette JA; Mithieux G; Rajas F
Diabetes; 2011 Dec; 60(12):3121-31. PubMed ID: 22013018
[TBL] [Abstract][Full Text] [Related]
11. The SMILE transcriptional corepressor inhibits cAMP response element-binding protein (CREB)-mediated transactivation of gluconeogenic genes.
Lee JM; Han HS; Jung YS; Harris RA; Koo SH; Choi HS
J Biol Chem; 2018 Aug; 293(34):13125-13133. PubMed ID: 29950523
[TBL] [Abstract][Full Text] [Related]
12. Dual role of the coactivator TORC2 in modulating hepatic glucose output and insulin signaling.
Canettieri G; Koo SH; Berdeaux R; Heredia J; Hedrick S; Zhang X; Montminy M
Cell Metab; 2005 Nov; 2(5):331-8. PubMed ID: 16271533
[TBL] [Abstract][Full Text] [Related]
13. Orphan nuclear receptor small heterodimer partner negatively regulates growth hormone-mediated induction of hepatic gluconeogenesis through inhibition of signal transducer and activator of transcription 5 (STAT5) transactivation.
Kim YD; Li T; Ahn SW; Kim DK; Lee JM; Hwang SL; Kim YH; Lee CH; Lee IK; Chiang JY; Choi HS
J Biol Chem; 2012 Oct; 287(44):37098-108. PubMed ID: 22977252
[TBL] [Abstract][Full Text] [Related]
14. Type I neuregulin1α is a novel local mediator to suppress hepatic gluconeogenesis in mice.
Arai T; Ono Y; Arimura Y; Sayama K; Suzuki T; Shinjo S; Kanai M; Abe SI; Semba K; Goda N
Sci Rep; 2017 Feb; 7():42959. PubMed ID: 28218289
[TBL] [Abstract][Full Text] [Related]
15. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B
J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor Y participates in alcoholic liver disease by activating SREBP1 expression in mice.
Zhang Y; Sun Y; Zhang Y; Miao Q; Wang Q; Yang B; Li Y; Li L; Zhang R
Biochem Biophys Res Commun; 2021 Feb; 541():90-94. PubMed ID: 33485268
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A-IV reduces hepatic gluconeogenesis through nuclear receptor NR1D1.
Li X; Xu M; Wang F; Kohan AB; Haas MK; Yang Q; Lou D; Obici S; Davidson WS; Tso P
J Biol Chem; 2014 Jan; 289(4):2396-404. PubMed ID: 24311788
[TBL] [Abstract][Full Text] [Related]
18. CD38-mediated Ca(2+) signaling contributes to glucagon-induced hepatic gluconeogenesis.
Rah SY; Kim UH
Sci Rep; 2015 Jun; 5():10741. PubMed ID: 26038839
[TBL] [Abstract][Full Text] [Related]
19. The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis.
Ploton M; Mazuy C; Gheeraert C; Dubois V; Berthier A; Dubois-Chevalier J; Maréchal X; Bantubungi K; Diemer H; Cianférani S; Strub JM; Helleboid-Chapman A; Eeckhoute J; Staels B; Lefebvre P
J Hepatol; 2018 Nov; 69(5):1099-1109. PubMed ID: 29981427
[TBL] [Abstract][Full Text] [Related]
20. Endoplasmic reticulum stress-induced activation of activating transcription factor 6 decreases cAMP-stimulated hepatic gluconeogenesis via inhibition of CREB.
Seo HY; Kim MK; Min AK; Kim HS; Ryu SY; Kim NK; Lee KM; Kim HJ; Choi HS; Lee KU; Park KG; Lee IK
Endocrinology; 2010 Feb; 151(2):561-8. PubMed ID: 20022930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
